vs

Side-by-side financial comparison of BIO KEY INTERNATIONAL INC (BKYI) and DBV Technologies S.A. (DBVT). Click either name above to swap in a different company.

DBV Technologies S.A. is the larger business by last-quarter revenue ($2.8M vs $1.5M, roughly 1.8× BIO KEY INTERNATIONAL INC). BIO KEY INTERNATIONAL INC runs the higher net margin — -62.3% vs -1195.5%, a 1133.3% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs -27.7%). BIO KEY INTERNATIONAL INC produced more free cash flow last quarter ($-1.1M vs $-32.6M). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -7.9%).

Bio Key International Inc develops and supplies biometric identity verification and access management solutions, including fingerprint, palm and facial recognition technologies. Its products serve enterprise, government, healthcare, education and retail sectors across North America, Europe and Asia, helping clients enhance security and streamline identity validation workflows.

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

BKYI vs DBVT — Head-to-Head

Bigger by revenue
DBVT
DBVT
1.8× larger
DBVT
$2.8M
$1.5M
BKYI
Growing faster (revenue YoY)
DBVT
DBVT
+186.5% gap
DBVT
158.8%
-27.7%
BKYI
Higher net margin
BKYI
BKYI
1133.3% more per $
BKYI
-62.3%
-1195.5%
DBVT
More free cash flow
BKYI
BKYI
$31.4M more FCF
BKYI
$-1.1M
$-32.6M
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-7.9%
BKYI

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
BKYI
BKYI
DBVT
DBVT
Revenue
$1.5M
$2.8M
Net Profit
$-964.8K
$-33.2M
Gross Margin
76.9%
Operating Margin
-57.6%
-1235.7%
Net Margin
-62.3%
-1195.5%
Revenue YoY
-27.7%
158.8%
Net Profit YoY
-30.6%
-8.9%
EPS (diluted)
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKYI
BKYI
DBVT
DBVT
Q3 25
$1.5M
$2.8M
Q2 25
$1.7M
$1.5M
Q1 25
$1.6M
Q4 24
$1.5M
Q3 24
$2.1M
Q2 24
$1.1M
$1.2M
Q1 24
$2.2M
$1.4M
Q4 23
$1.8M
$8.9M
Net Profit
BKYI
BKYI
DBVT
DBVT
Q3 25
$-964.8K
$-33.2M
Q2 25
$-1.2M
$-41.9M
Q1 25
$-736.5K
Q4 24
$-1.4M
Q3 24
$-739.0K
Q2 24
$-1.7M
$-33.1M
Q1 24
$-510.3K
$-27.3M
Q4 23
$-2.5M
$134.3M
Gross Margin
BKYI
BKYI
DBVT
DBVT
Q3 25
76.9%
Q2 25
72.6%
Q1 25
82.6%
Q4 24
82.1%
Q3 24
78.3%
Q2 24
77.0%
Q1 24
86.3%
Q4 23
-5.2%
Operating Margin
BKYI
BKYI
DBVT
DBVT
Q3 25
-57.6%
-1235.7%
Q2 25
-63.9%
-2806.2%
Q1 25
-39.9%
Q4 24
-86.7%
Q3 24
-27.1%
Q2 24
-144.9%
-2914.9%
Q1 24
-23.3%
-2029.7%
Q4 23
-149.2%
-134.3%
Net Margin
BKYI
BKYI
DBVT
DBVT
Q3 25
-62.3%
-1195.5%
Q2 25
-68.8%
-2858.4%
Q1 25
-45.8%
Q4 24
-94.7%
Q3 24
-34.5%
Q2 24
-146.1%
-2852.4%
Q1 24
-23.4%
-1943.5%
Q4 23
-137.8%
1512.8%
EPS (diluted)
BKYI
BKYI
DBVT
DBVT
Q3 25
$-0.24
Q2 25
$-0.31
Q1 25
Q4 24
Q3 24
Q2 24
$-0.34
Q1 24
$-0.28
Q4 23
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKYI
BKYI
DBVT
DBVT
Cash + ST InvestmentsLiquidity on hand
$2.0M
$69.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$6.0M
$52.9M
Total Assets
$10.1M
$110.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKYI
BKYI
DBVT
DBVT
Q3 25
$2.0M
$69.8M
Q2 25
$2.3M
$103.2M
Q1 25
$3.1M
Q4 24
$437.6K
Q3 24
$1.8M
Q2 24
$1.3M
$66.2M
Q1 24
$690.4K
$101.5M
Q4 23
$511.4K
$141.4M
Stockholders' Equity
BKYI
BKYI
DBVT
DBVT
Q3 25
$6.0M
$52.9M
Q2 25
$6.9M
$86.2M
Q1 25
$7.5M
Q4 24
$3.8M
Q3 24
$133.0K
Q2 24
$-1.1M
$79.1M
Q1 24
$535.7K
$111.7M
Q4 23
$1.1M
$140.2M
Total Assets
BKYI
BKYI
DBVT
DBVT
Q3 25
$10.1M
$110.5M
Q2 25
$10.5M
$143.4M
Q1 25
$11.2M
Q4 24
$8.6M
Q3 24
$6.4M
Q2 24
$4.8M
$114.2M
Q1 24
$4.2M
$145.9M
Q4 23
$4.5M
$183.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKYI
BKYI
DBVT
DBVT
Operating Cash FlowLast quarter
$-1.1M
$-32.4M
Free Cash FlowOCF − Capex
$-1.1M
$-32.6M
FCF MarginFCF / Revenue
-72.5%
-1173.5%
Capex IntensityCapex / Revenue
0.1%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.4M
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKYI
BKYI
DBVT
DBVT
Q3 25
$-1.1M
$-32.4M
Q2 25
$-880.0K
$-33.9M
Q1 25
$-835.3K
Q4 24
$-514.6K
Q3 24
$-1.3M
Q2 24
$-1.4M
$-35.1M
Q1 24
$297.1K
$-34.7M
Q4 23
$-1.5M
$-13.7M
Free Cash Flow
BKYI
BKYI
DBVT
DBVT
Q3 25
$-1.1M
$-32.6M
Q2 25
$-881.5K
$-33.9M
Q1 25
$-839.9K
Q4 24
$-524.6K
Q3 24
$-1.3M
Q2 24
$-35.8M
Q1 24
$295.2K
$-36.0M
Q4 23
$-1.5M
$-14.0M
FCF Margin
BKYI
BKYI
DBVT
DBVT
Q3 25
-72.5%
-1173.5%
Q2 25
-51.9%
-2316.5%
Q1 25
-52.3%
Q4 24
-35.9%
Q3 24
-60.5%
Q2 24
-3084.0%
Q1 24
13.5%
-2560.6%
Q4 23
-84.0%
-158.2%
Capex Intensity
BKYI
BKYI
DBVT
DBVT
Q3 25
0.1%
4.2%
Q2 25
0.1%
2.2%
Q1 25
0.3%
Q4 24
0.7%
Q3 24
1.0%
Q2 24
0.0%
63.0%
Q1 24
0.1%
94.9%
Q4 23
0.1%
4.0%
Cash Conversion
BKYI
BKYI
DBVT
DBVT
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
-0.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons